PERSPECTA

News from every angle

← Back to headlines

BrainStorm Cell Therapeutics Reports GAAP EPS of -$0.35

BrainStorm Cell Therapeutics released its latest financial report, indicating a GAAP EPS of -$0.35.

17 Aug, 07:23 — 17 Aug, 07:23
PostShare

Sources

Showing 1 of 1 sources
seeking-alphaMixed9h ago

BrainStorm Cell Therapeutics GAAP EPS of -$0.35

Read full article →

Related Stories

Morgan Stanley's Troubling Housing Forecast Materializes

36m ago

UK Vodka Brand Au Agrees £500M Takeover by US Giant

37m ago

Fulcrum Therapeutics Stock Rises on Slate Medicines Merger Deal for Migraine Therapies

42m ago

Dutch Sports Car Manufacturer Spyker Returns with New Model

51m ago